Literature DB >> 7856471

Subarachnoid hemorrhage of unknown origin. A 44 cases study.

S Congia1, S Carta, M Coraddu.   

Abstract

44 cases (20 men and 24 women) of subarachnoid hemorrhage (SAH) of unknown origin were studied: the mean age was 54.1 yrs. Highest frequency of the disease was observed in 51-70 years old patients. There was only a slight involvement of consciousness (I-II grade of HESS and HUNT). Vascular hypertension was noticed in 45.5% of patients, but outcome did not differ in hypertensive and normotensive subjects. The CT findings showed a typical picture of SAH. 4 cases of perimesencephalic and peripontine hemorrhage were noticed. 24 patients underwent lumbar puncture. The angiographic study was normal in all patients. 14 subjects repeated four-vessel angiography. Transient hydrocephalus was found in 22.7% of patients. Approximately 70% of patients received antifibrinolytic therapy, either with or without calcium entry-blockers (nimodipine). Neither ischemic complications nor rebleeding were observed. Follow-up showed that all patients had survived 7-88 months after SAH. All subjects made a complete recovery and have since been able to resume work.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7856471

Source DB:  PubMed          Journal:  Acta Neurol (Napoli)        ISSN: 0001-6276


  3 in total

1.  Clinical differences between angiographically negative, diffuse subarachnoid hemorrhage and perimesencephalic subarachnoid hemorrhage.

Authors:  Ferdinand K Hui; Luis M Tumialán; Tomoko Tanaka; C Michael Cawley; Y Jonathan Zhang
Journal:  Neurocrit Care       Date:  2009-03-10       Impact factor: 3.210

2.  Spinal vascular malformations in non-perimesencephalic subarachnoid hemorrhage.

Authors:  M R Germans; F A Pennings; M E S Sprengers; W P Vandertop
Journal:  J Neurol       Date:  2009-01-23       Impact factor: 4.849

3.  Stress-Induced Subarachnoid Hemorrhage: A Case Report.

Authors:  Charlotte Ritchie; Qamar Al Tinawi; Mostafa Mahmoud Fahmy; Mohammad Selim
Journal:  Cureus       Date:  2022-07-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.